Volume 14, Issue 4 (Winter 2017)                   Sci J Iran Blood Transfus Organ 2017, 14(4): 367-372 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Samadi E, Mirshahabi H, Motamed N. ASeroepidemiologic of Blood-Borne Viruses in Hemodialysis Patients in Zanjan City. Sci J Iran Blood Transfus Organ 2017; 14 (4) :367-372
URL: http://bloodjournal.ir/article-1-1129-en.html
ASeroepidemiologic of Blood-Borne Viruses in Hemodialysis Patients in Zanjan City
E. Samadi , H. Mirshahabi * , N. Motamed
Keywords: Hepatitis B, Hepatitic C, HIV, Hemodialysis
Full-Text [PDF 210 kb]   (1477 Downloads)     |   Abstract (HTML)  (4513 Views)
Full-Text:   (1928 Views)
    References:
 
 
  1. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman Province, South-East Iran. Hepat Mon 2012; 12(5): 339-43.
  2. Mittal G, Gupta P, Thakuria B, Mukhiya GK, Mittal M. Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. J Clin Exp Hepatol 2013; 3(1): 24-8.
  3. Yuan J, Yang Y, Han F, Zhang P, Du XY, Jiang H, et al. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus. Hepatobiliary Pancreat Dis Int 2012; 11(3): 302-6.
  4. Bosevska G, Kuzmanovska G, Sikole A, Dzekova-Vidimliski P, Polenakovic M. Screening for hepatitis b, c and hiv infection among patients on haemodialysis. Contributions of Macedonian Academy of Sciences & Arts 2009; 30(2): 159-74.
  5. Elamin S, Abu-Aisha H. Prevention of hepatitis B virus and hepatitis C virus transmission in hemodialysis centers: review of current international recommendations. Arab J Nephrol Transplant 2011; 4(1): 35-47.
  6. Mahdavimazdeh M, Hosseini-Moghaddam SM, Alavian SM, Yahyazadeh H. Hepatitis B Infection in hemodialysis  patients  in  Tehran province, Iran. Hepat
Mon 2009; 9(3): 206-10.
  1. Selm SB. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen. Saudi J Kidney Diseases and Transplantation 2010; 21(6): 1165-8.
  2. Merat S, Rezvan H, Nouraie M, Jamali A, Assari S, Abolghasemi H, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 2009; 12(3): 225-31.
  3. Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 178-81.
  4. Amini Kafi-abad S, Rezvan H, Abolghasemi H, Talebian A. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 2009; 49(10): 2214-20.
  5. Alavian SM, Kabir A, Ahmadi AB, Lankarani KB, Shahbabaie MA, Ahmadzad-Asl M.. Hepatitis C infection in hemodialysis patients in Iran: a systematic review. Hemodial Int 2010; 14(3): 253-62.
  6. Sabor B BP, Mehrabi Y, GHanbari M, Zarrinfam H. Prevalence and distribution risk factors of hepatitis C in hemodialysis patients of Kermanshah Province. Journal of Kermanshah University of Medical Sciences
2004; 3: 60-6. [Article in Farsi]
  1. Tajbakhsh R. Prevalence of hepatitis C and B virus infections among hemodialysis patients in Karaj, Iran. Saudi Journal of Kidney Diseases and Transplantation 2015; 26(4): 792.
  2. Hosseini-Moghaddam SM, Keyvani H, Kasiri H, Kazemeyni SM, Basiri A, Aghel N, et al. Distribution of hepatitis C virus genotypes among hemodialysis patients in Tehran--a multicenter study. J Med Virol 2006; 78(5): 569-73.
  3. Samimi rad K, Shahbaz B, Noroozi M, Mahmoodi M, Fayaz Vaseghi M. Prevalence of Hepatitis C virus
    antibody and related risk factors among hemodialysis patients in Markazi province (2004). Arak Medical University Journal 2006; 9(1): 23-33. [Article in Farsi]
  4. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int 2008; 12(3): 378-82.
  5. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B Virus infection in Iran: A systematic review. Hepat Mon 2008; 8(4): 281-94.
 
 
 


 
 
 
 
Sci J Iran Blood Transfus Organ 2018; 14(4): 367-372
Short  Communication
 

 

ASeroepidemiologic of Blood-Borne Viruses in Hemodialysis Patients in Zanjan City
 
Samadi E.1, Mirshahabi H.1, Motamed N.1
 
 
 
1Faculty of Medical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran
 
 
 
Abstract
Background and Objectives
Hemodialysis is a major method of treatment for the patients of end-stage renal disease (ESRD). It so disposes them to some infections, specially blood born viruses. The aim of this study was to investigate the prevalence of serological markers for HBsAg, anti-HBs, anti-HCV and HIV Ab in hemodialysis patients in Zanjan city.
 
Materials and Methods
After 10 ml blood samples were used for detection of markers for hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (HBs Ab), antibody to HCV (anti-HCV), HIV antibody by ECL. Data were analyzed by c2, t test and fisher exact test.
 
Results
Positive HBsAg was found in .2.3%, HBs Ab 65.3% and HCV Ab 1.1% of cases. HIV Ab cases were negative in these patients.
 
Conclusions 
The prevalence of HBsAg in hemodialysis patients has been re­ported to be lower than in the general population. In this study, the prevalence of HBs Ab compared to other studies in Iran and other countries is not much different. The results show that the prevalence of HCV Ab in hemodialysis patients is the same with the general population and the prevalence of HIV Ab in this study is similar to the result recent studies.
 
Key words: Hepatitis B, Hepatitic C, HIV, Hemodialysis
 
 
 
 
 
 
 
 
 
 
Received: 21 Jun 2017
Accepted:  9 Oct 2017
 
 

Correspondence: Mirshahabi H., PhD of Medical Virology. Assistant professor of Faculty of Medical Sciences, Zanjan University of Medical Sciences.
PostalCode: 4513956111, Zanjan, Iran. Tel: (+9824) 33140290; Fax: (+9824) 33449553
E-mail:
mirshahabi@zums.ac.ir
Type of Study: Short Communication | Subject: Virology
Published: 2018/01/2
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb